{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:07:27Z","timestamp":1795090047876,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TO10-13"],"award-info":[{"award-number":["TO10-13"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1192"],"award-info":[{"award-number":["SFB1192"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Membranous nephropathy (MN) is an antibody-mediated autoimmune disease characterized by glomerular immune complexes containing complement components. However, both the initiation pathways and the pathogenic significance of complement activation in MN are poorly understood. Here, we show that components from all three complement pathways (alternative, classical and lectin) are found in renal biopsies from patients with MN. Proximity ligation assays to directly visualize complement assembly in the tissue reveal dominant activation via the classical pathway, with a close correlation to the degree of glomerular C1q-binding IgG subclasses. In an antigen-specific autoimmune mouse model of MN, glomerular damage and proteinuria are reduced in complement-deficient mice compared with wild-type littermates. Severe disease with progressive ascites, accompanied by extensive loss of the integral podocyte slit diaphragm proteins, nephrin and neph1, only occur in wild-type animals. Finally, targeted silencing of C3 using RNA interference after the onset of proteinuria significantly attenuates disease. Our study shows that, in MN, complement is primarily activated via the classical pathway and targeting complement components such as C3 may represent a promising therapeutic strategy.<\/jats:p>","DOI":"10.1038\/s41467-023-36068-0","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:02:50Z","timestamp":1674900170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["The classical pathway triggers pathogenic complement activation in membranous nephropathy"],"prefix":"10.1038","volume":"14","author":[{"given":"Larissa","family":"Seifert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Zahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meyer-Schwesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naemi","family":"Hickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Dehde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3169-0732","authenticated-orcid":false,"given":"Sonia","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M. S.","family":"K\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Kylies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Froembling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Borodovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Biniaminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Koch-Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Hopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-5462","authenticated-orcid":false,"given":"Victor G.","family":"Puelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-5062","authenticated-orcid":false,"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-1474","authenticated-orcid":false,"given":"Thorsten","family":"Wiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-9862","authenticated-orcid":false,"given":"Nicola M.","family":"Tomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"36068_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0272-6386(00)70316-7","volume":"35","author":"P Maisonneuve","year":"2000","unstructured":"Maisonneuve, P. et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia\/New Zealand: results from an international comparative study. Am. J. Kidney Dis. 35, 157\u2013165 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"36068_CR2","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1053\/j.ajkd.2015.07.006","volume":"66","author":"AB Fogo","year":"2015","unstructured":"Fogo, A. B., Lusco, M. A., Najafian, B. & Alpers, C. E. AJKD atlas of renal pathology: membranous nephropathy. Am. J. Kidney Dis. 66, e15\u2013e17 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"36068_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","volume":"25","author":"Y Segawa","year":"2010","unstructured":"Segawa, Y. et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr. Nephrol. 25, 1091\u20131099 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"36068_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr.","year":"2009","unstructured":"Beck, L. H. Jr. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11\u201321 (2009).","journal-title":"N. Engl. J. Med."},{"key":"36068_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas, N. M. et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med. 371, 2277\u20132287 (2014).","journal-title":"N. Engl. J. Med."},{"key":"36068_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi, S. et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 97, 163\u2013174 (2020).","journal-title":"Kidney Int."},{"key":"36068_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","volume":"98","author":"S Sethi","year":"2020","unstructured":"Sethi, S. et al. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int. 98, 1253\u20131264 (2020).","journal-title":"Kidney Int."},{"key":"36068_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.kint.2020.07.039","volume":"99","author":"T Caza","year":"2020","unstructured":"Caza, T. et al. NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int. 99, 967\u2013976 (2020).","journal-title":"Kidney Int."},{"key":"36068_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi, S. et al. Protocadherin 7-associated membranous nephropathy. J. Am. Soc. Nephrol. 32, 1249\u20131261 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1681\/ASN.2020101395","volume":"32","author":"LF Al-Rabadi","year":"2021","unstructured":"Al-Rabadi, L. F. et al. Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy. J. Am. Soc. Nephrol. 32, 1666\u20131681 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front. Immunol. 5, 520 (2014).","journal-title":"Front. Immunol."},{"key":"36068_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/ajcp\/83.4.415","volume":"83","author":"JC Jennette","year":"1985","unstructured":"Jennette, J. C. & Hipp, C. G. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am. J. Clin. Pathol. 83, 415\u2013420 (1985).","journal-title":"Am. J. Clin. Pathol."},{"key":"36068_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5935\/0101-2800.20170068","volume":"39","author":"FB Custodio","year":"2017","unstructured":"Custodio, F. B., Silva, C. A. D., Helmo, F. R., Machado, J. R. & Reis, M. A. D. Complement system and C4d expression in cases of Membranous nephropathy. J. Bras. Nefrol. 39, 370\u2013375 (2017).","journal-title":"J. Bras. Nefrol."},{"key":"36068_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cca.2018.06.050","volume":"485","author":"MF Zhang","year":"2018","unstructured":"Zhang, M. F. et al. Clinical and prognostic significance of glomerular C1q deposits in primary MN. Clin. Chim. Acta 485, 152\u2013157 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"36068_CR15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41379-019-0267-z","volume":"32","author":"T Wiech","year":"2019","unstructured":"Wiech, T., Stahl, R. A. K. & Hoxha, E. Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome. Mod. Pathol. 32, 1320\u20131328 (2019).","journal-title":"Mod. Pathol."},{"key":"36068_CR16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2012030242","volume":"23","author":"JM Hofstra","year":"2012","unstructured":"Hofstra, J. M. et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 23, 1735\u20131743 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR17","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1681\/ASN.2017070805","volume":"29","author":"L Seifert","year":"2018","unstructured":"Seifert, L. et al. The most N-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-Associated Membranous Nephropathy. J. Am. Soc. Nephrol. 29, 1536\u20131548 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR18","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.3389\/fimmu.2018.03035","volume":"9","author":"F von Haxthausen","year":"2018","unstructured":"von Haxthausen, F. et al. Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy. Front. Immunol. 9, 3035 (2018).","journal-title":"Front. Immunol."},{"key":"36068_CR19","doi-asserted-by":"publisher","first-page":"1324804","DOI":"10.1155\/2019\/1324804","volume":"2019","author":"M Lateb","year":"2019","unstructured":"Lateb, M. et al. Anti-PLA2R1 antibodies containing sera induce in vitro cytotoxicity mediated by complement activation. J. Immunol. Res. 2019, 1324804 (2019).","journal-title":"J. Immunol. Res."},{"key":"36068_CR20","first-page":"57","volume":"58","author":"T Doi","year":"1984","unstructured":"Doi, T., Mayumi, M., Kanatsu, K., Suehiro, F. & Hamashima, Y. Distribution of IgG subclasses in membranous nephropathy. Clin. Exp. Immunol. 58, 57\u201362 (1984).","journal-title":"Clin. Exp. Immunol."},{"key":"36068_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ekir.2020.01.018","volume":"5","author":"A Ravindran","year":"2020","unstructured":"Ravindran, A. et al. Proteomic analysis of complement proteins in membranous nephropathy. Kidney Int. Rep. 5, 618\u2013626 (2020).","journal-title":"Kidney Int. Rep."},{"key":"36068_CR22","first-page":"1391","volume":"26","author":"JF Val-Bernal","year":"2011","unstructured":"Val-Bernal, J. F., Garijo, M. F., Val, D., Rodrigo, E. & Arias, M. C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histol. Histopathol. 26, 1391\u20131397 (2011).","journal-title":"Histol. Histopathol."},{"key":"36068_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/ndt\/gfx235","volume":"33","author":"N Hayashi","year":"2018","unstructured":"Hayashi, N. et al. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy. Nephrol. Dial. Transpl. 33, 832\u2013840 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"36068_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ndt\/14.4.881","volume":"14","author":"K Lhotta","year":"1999","unstructured":"Lhotta, K., Wurzner, R. & Konig, P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol. Dial. Transpl. 14, 881\u2013886 (1999).","journal-title":"Nephrol. Dial. Transpl."},{"key":"36068_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1159\/000508665","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Effect of glomerular mannose-binding lectin deposition on the prognosis of idiopathic membranous nephropathy. Kidney Blood Press Res. 45, 713\u2013726 (2020).","journal-title":"Kidney Blood Press Res."},{"key":"36068_CR26","doi-asserted-by":"publisher","first-page":"e140453","DOI":"10.1172\/JCI140453","volume":"131","author":"G Haddad","year":"2021","unstructured":"Haddad, G. et al. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. J. Clin. Invest. 131, e140453 (2021).","journal-title":"J. Clin. Invest."},{"key":"36068_CR27","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1681\/ASN.2015101155","volume":"27","author":"S Bally","year":"2016","unstructured":"Bally, S. et al. Phospholipase A2 receptor-related membranous nephropathy and mannan-binding lectin deficiency. J. Am. Soc. Nephrol. 27, 3539\u20133544 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1746-1596-7-109","volume":"7","author":"R Zhang","year":"2012","unstructured":"Zhang, R., Zheng, Z. Y., Lin, J. S., Qu, L. J. & Zheng, F. The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment. Diagn. Pathol. 7, 109 (2012).","journal-title":"Diagn. Pathol."},{"key":"36068_CR29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2004121098","volume":"16","author":"M Nangaku","year":"2005","unstructured":"Nangaku, M., Shankland, S. J. & Couser, W. G. Cellular response to injury in membranous nephropathy. J. Am. Soc. Nephrol. 16, 1195\u20131204 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0161-5890(01)00039-6","volume":"38","author":"UR Nilsson","year":"2001","unstructured":"Nilsson, U. R. Deposition of C3b\/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol. Immunol. 38, 151\u2013160 (2001).","journal-title":"Mol. Immunol."},{"key":"36068_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.ekir.2020.03.009","volume":"5","author":"F Person","year":"2020","unstructured":"Person, F. et al. In situ visualization of C3\/C5 convertases to differentiate complement activation. Kidney Int. Rep. 5, 927\u2013930 (2020).","journal-title":"Kidney Int. Rep."},{"key":"36068_CR32","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1172\/JCI85265","volume":"126","author":"NM Tomas","year":"2016","unstructured":"Tomas, N. M. et al. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. J. Clin. Invest. 126, 2519\u20132532 (2016).","journal-title":"J. Clin. Invest."},{"key":"36068_CR33","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J. Immunol. 164, 6166\u20136173 (2000).","journal-title":"J. Immunol."},{"key":"36068_CR34","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.181.2.713","volume":"181","author":"CS Hsieh","year":"1995","unstructured":"Hsieh, C. S., Macatonia, S. E., O\u2019Garra, A. & Murphy, K. M. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181, 713\u2013721 (1995).","journal-title":"J. Exp. Med."},{"key":"36068_CR35","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1681\/ASN.2017010030","volume":"28","author":"NM Tomas","year":"2017","unstructured":"Tomas, N. M. et al. A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy. J. Am. Soc. Nephrol. 28, 3262\u20133277 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR36","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/icb.2016.65","volume":"94","author":"AM Collins","year":"2016","unstructured":"Collins, A. M. IgG subclass co-expression brings harmony to the quartet model of murine IgG function. Immunol. Cell Biol. 94, 949\u2013954 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"36068_CR37","doi-asserted-by":"publisher","first-page":"F660","DOI":"10.1152\/ajprenal.00437.2004","volume":"289","author":"AV Cybulsky","year":"2005","unstructured":"Cybulsky, A. V., Quigg, R. J. & Salant, D. J. Experimental membranous nephropathy redux. Am. J. Physiol. Ren. Physiol. 289, F660\u2013F671 (2005).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"36068_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fmed.2018.00292","volume":"5","author":"N Artelt","year":"2018","unstructured":"Artelt, N. et al. Comparative analysis of podocyte foot process morphology in three species by 3D super-resolution microscopy. Front. Med. 5, 292 (2018).","journal-title":"Front. Med."},{"key":"36068_CR39","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1681\/ASN.2020091346","volume":"32","author":"F Hatje","year":"2021","unstructured":"Hatje, F. et al. Tripartite separation of glomerular cell-types and proteomes from reporter-free mice. J. Am. Soc. Nephrol. 32, 2175\u20132193 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR40","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1681\/ASN.2020091346","volume":"32","author":"FA Hatje","year":"2021","unstructured":"Hatje, F. A. et al. Tripartite separation of glomerular cell types and proteomes from reporter-free mice. J. Am. Soc. Nephrol. 32, 2175\u20132193 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR41","doi-asserted-by":"publisher","first-page":"952235","DOI":"10.3389\/fimmu.2022.952235","volume":"13","author":"P Manral","year":"2022","unstructured":"Manral, P., Caza, T. N., Storey, A. J., Beck, L. H. Jr. & Borza, D. B. The alternative pathway is necessary and sufficient for complement activation by anti-THSD7A autoantibodies, which are predominantly IgG4 in membranous nephropathy. Front. Immunol. 13, 952235 (2022).","journal-title":"Front. Immunol."},{"key":"36068_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","volume":"26","author":"CC Huang","year":"2013","unstructured":"Huang, C. C. et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod. Pathol. 26, 799\u2013805 (2013).","journal-title":"Mod. Pathol."},{"key":"36068_CR43","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ki.1992.166","volume":"41","author":"D Kerjaschki","year":"1992","unstructured":"Kerjaschki, D. Molecular pathogenesis of membranous nephropathy. Kidney Int. 41, 1090\u20131105 (1992).","journal-title":"Kidney Int."},{"key":"36068_CR44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ki.1985.214","volume":"28","author":"WG Couser","year":"1985","unstructured":"Couser, W. G., Baker, P. J. & Adler, S. Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int 28, 879\u2013890 (1985).","journal-title":"Kidney Int"},{"key":"36068_CR45","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI109987","volume":"66","author":"DJ Salant","year":"1980","unstructured":"Salant, D. J., Belok, S., Madaio, M. P. & Couser, W. G. A new role for complement in experimental membranous nephropathy in rats. J. Clin. Invest. 66, 1339\u20131350 (1980).","journal-title":"J. Clin. Invest."},{"key":"36068_CR46","first-page":"185","volume":"135","author":"PJ Baker","year":"1989","unstructured":"Baker, P. J. et al. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am. J. Pathol. 135, 185\u2013194 (1989).","journal-title":"Am. J. Pathol."},{"key":"36068_CR47","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1073\/pnas.1820892116","volume":"116","author":"A Schubart","year":"2019","unstructured":"Schubart, A. et al. Small-molecule factor B inhibitor for the treatment of complement-mediated diseases. Proc. Natl Acad. Sci. USA 116, 7926\u20137931 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36068_CR48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/ki.1995.224","volume":"47","author":"PL Leenaerts","year":"1995","unstructured":"Leenaerts, P. L., Hall, B. M., Van Damme, B. J., Daha, M. R. & Vanrenterghem, Y. F. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 47, 1604\u20131614 (1995).","journal-title":"Kidney Int."},{"key":"36068_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.179.1.172","volume":"179","author":"ST Spicer","year":"2007","unstructured":"Spicer, S. T. et al. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J. Immunol. 179, 172\u2013178 (2007).","journal-title":"J. Immunol."},{"key":"36068_CR50","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.kint.2019.10.022","volume":"97","author":"C Meyer-Schwesinger","year":"2020","unstructured":"Meyer-Schwesinger, C. et al. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients. Kidney Int. 97, 913\u2013919 (2020).","journal-title":"Kidney Int."},{"key":"36068_CR51","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","volume":"79","author":"D Kerjaschki","year":"1982","unstructured":"Kerjaschki, D. & Farquhar, M. G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl Acad. Sci. USA 79, 5557\u20135561 (1982).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36068_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1681\/ASN.2019050538","volume":"31","author":"PD Burbelo","year":"2020","unstructured":"Burbelo, P. D. et al. Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J. Am. Soc. Nephrol. 31, 208\u2013217 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR53","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1128\/MCB.21.14.4829-4836.2001","volume":"21","author":"DB Donoviel","year":"2001","unstructured":"Donoviel, D. B. et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol. Cell Biol. 21, 4829\u20134836 (2001).","journal-title":"Mol. Cell Biol."},{"key":"36068_CR54","doi-asserted-by":"publisher","first-page":"e86177","DOI":"10.1172\/jci.insight.86177","volume":"1","author":"F Grahammer","year":"2016","unstructured":"Grahammer, F. et al. A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes. JCI Insight 1, e86177 (2016).","journal-title":"JCI Insight"},{"key":"36068_CR55","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3389\/fimmu.2019.02166","volume":"10","author":"PF Zipfel","year":"2019","unstructured":"Zipfel, P. F. et al. Complement inhibitors in clinical trials for glomerular diseases. Front. Immunol. 10, 2166 (2019).","journal-title":"Front. Immunol."},{"key":"36068_CR56","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ki.2014.381","volume":"87","author":"M Vivarelli","year":"2015","unstructured":"Vivarelli, M. et al. Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies. Kidney Int. 87, 602\u2013609 (2015).","journal-title":"Kidney Int."},{"key":"36068_CR57","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1681\/ASN.2021101384","volume":"33","author":"S Gao","year":"2022","unstructured":"Gao, S., Cui, Z. & Zhao, M. H. Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy. J. Am. Soc. Nephrol. 33, 1742\u20131756 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36068_CR58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ki.2012.209","volume":"82","author":"E Hoxha","year":"2012","unstructured":"Hoxha, E. et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 82, 797\u2013804 (2012).","journal-title":"Kidney Int."},{"key":"36068_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10163","volume":"474","author":"WC Skarnes","year":"2011","unstructured":"Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337\u2013342 (2011).","journal-title":"Nature"},{"key":"36068_CR60","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/ja505986a","volume":"136","author":"JK Nair","year":"2014","unstructured":"Nair, J. K. et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958\u201316961 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"36068_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11013-2","volume":"10","author":"H Lazareth","year":"2019","unstructured":"Lazareth, H. et al. The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression. Nat. Commun. 10, 3303 (2019).","journal-title":"Nat. Commun."},{"key":"36068_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11553-x","volume":"7","author":"F Siegerist","year":"2017","unstructured":"Siegerist, F. et al. Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement. Sci. Rep. 7, 11473 (2017).","journal-title":"Sci. Rep."},{"key":"36068_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-59745-554-1_17","volume":"525","author":"J Zhang","year":"2009","unstructured":"Zhang, J., MacKenzie, R. & Durocher, Y. Production of chimeric heavy-chain antibodies. Methods Mol. Biol. 525, 323\u2013336 (2009).","journal-title":"Methods Mol. Biol."},{"key":"36068_CR64","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.omtm.2019.04.009","volume":"13","author":"LL Kusner","year":"2019","unstructured":"Kusner, L. L. et al. Investigational RNAi therapeutic targeting C5 is efficacious in pre-clinical models of myasthenia gravis. Mol. Ther. Methods Clin. Dev. 13, 484\u2013492 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36068-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:06:40Z","timestamp":1675001200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36068-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36068"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36068-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742511859.793597763","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. is an employee and shareholder of Alnylam Pharmaceuticals. P.F.Z. serves as a consultant for Eleva GMBH, Novartis, Generic Assays, Alexion, Bayer, Vifor Fresenius Medical Care Renal Pharma, and Samsung Bioepis. All other authors declare no competing interests. P.F., S.W., and T.W. applied for a patent \u201cC3\/C5 convertase assays\u201d (EP 3771468\/US-2022-0276261).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"473"}}